![]() |
市場調查報告書
商品編碼
2126745
醫用不織布一次性產品市場:依產品類型和地區分類Medical Nonwoven Disposables Market, By Product Type (Surgical product, Wound dressings, and Incontinence product), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa) |
||||||
預計2026年,醫用不織布一次性產品市場規模將達364.5億美元,2033年將達868.3億美元。預計2026年至2033年,該市場將以13.2%的複合年成長率成長。
| 報告範圍 | 報告詳情 | ||
|---|---|---|---|
| 基準年: | 2025 | 2026年市場規模: | 364.5億美元 |
| 歷史數據時期: | 2020年至2024年 | 預測期: | 2026年至2033年 |
| 2026年至2033年預測期間的複合年成長率: | 13.20% | 2033年市場規模預測: | 868.3億美元 |
該市場正經歷強勁成長,主要促進因素包括醫療相關感染的增加、一次性醫療產品消費量的成長、外科手術和門診治療的增多,以及對感染預防和患者安全日益重視。一次性不織布醫療產品是指採用不織布結構製造的一次性醫療產品,包括手術罩衣、手術鋪巾、口罩、無菌包紮物、傷口敷料、吸收性產品和失禁用品。
在醫療機構中,一次性防護產品對於降低交叉感染風險和維持無菌臨床環境的重要性日益凸顯。手術產品在手術室和門診持續需求的推動下,預計到2026年將佔據約45.0%的市場佔有率。同時,隨著多功能創傷護理材料、配備感測器的智慧敷料、高性能防護織物以及可回收或生物基不織布材料的進步,該行業的技術範圍也在不斷擴大。
此外,醫院、門診手術中心、長期照護機構和居家醫療等基礎設施的擴建也推動了市場成長。糖尿病相關慢性傷口的日益普遍、人口老化、身體功能障礙以及對長期照護需求的成長,都推動了對傷口敷料和可吸收失禁用品的需求。預計到2026年,北美將引領全球市場,佔據約38.0%的市場佔有率,而亞太地區預計將在預測期內成為成長最快的區域市場。
由於慢性傷口和糖尿病併發症負擔日益加重、手術數量不斷增加以及對感染控制產品的需求日益成長,市場呈現出強勁的成長勢頭。不織布傷口敷料、吸水墊、手術罩衣、手術單、口罩、無菌包裝膜和其他屏障產品廣泛應用於醫院、門診手術中心、門診機構和長期照護機構。由於這些產品大多可重複使用且為一次性產品,因此對替換品的需求持續存在,從而支撐了醫療機構的持續採購。
醫療基礎設施和機構護理網路的擴張進一步推動了市場成長。醫院容量的增加、門診手術量的上升、人口老化以及復健護理和居家醫療服務的日益普及,都帶動了對外科產品、一次性傷口護理產品、床墊、成人失禁用品及相關醫療用品的需求。亞太地區尤其受益於醫療服務可及性的提高和醫院基礎設施的改善,而美國等成熟市場則憑藉大規模的老齡人口和完善的康復護理網路,持續創造著穩定的需求。
產品創新和監管趨勢也在重塑競爭格局。製造商正不斷研發先進的吸收材料、智慧傷口敷料、抗菌和X光可見材料、永續纖維以及減少塑膠使用的解決方案。同時,諸如將於2026年2月2日生效的美國FDA品管系統法規等,正在加強對醫療設備製造商在品管、供應商管理、風險管理、文件記錄和檢驗合規方面的要求。然而,一次性醫療廢棄物日益嚴重的環境問題,以及相對較高的原料和製造成本,仍是參與企業面臨的重大挑戰。
Medical Nonwoven Disposables Market is estimated to be valued at USD 36.45 Bn in 2026 and is expected to reach USD 86.83 Bn by 2033, growing at a compound annual growth rate (CAGR) of 13.2% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 36.45 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 13.20% | 2033 Value Projection: | USD 86.83 Bn |
The market is witnessing strong growth primarily driven by the increasing prevalence of healthcare-associated infections, rising consumption of single-use medical products, growing surgical and outpatient procedure volumes, and increasing emphasis on infection prevention and patient safety. Medical nonwoven disposables comprise single-use healthcare products manufactured using nonwoven fiber structures and include surgical gowns, drapes, masks, sterilization wraps, wound dressings, absorbent products, and incontinence products.
Healthcare facilities are increasingly emphasizing disposable barrier products to reduce cross-contamination risks and maintain sterile clinical environments. Surgical products are expected to account for approximately 45.0% of the market in 2026, supported by recurring consumption across operating rooms and outpatient procedural settings. At the same time, advances in multifunctional wound-care materials, sensor-enabled smart dressings, high-performance barrier fabrics, and recyclable or bio-based nonwoven materials are expanding the technological scope of the industry.
The market is also benefiting from the expansion of hospital, ambulatory surgical, long-term care, and home healthcare infrastructure. Demand for wound dressings and absorbent incontinence products is being reinforced by the increasing prevalence of diabetes-associated chronic wounds, population ageing, mobility limitations, and long-term care requirements. North America is expected to dominate the global market with approximately 38.0% share in 2026, while Asia Pacific is anticipated to emerge as the fastest-growing regional market during the forecast period.
The market is witnessing substantial momentum owing to the increasing burden of chronic wounds and diabetic complications, rising surgical volumes, and growing demand for infection-control products. Nonwoven wound dressings, absorbent pads, surgical gowns, drapes, masks, sterilization wraps, and other barrier products are extensively consumed across hospitals, ambulatory surgical centers, outpatient facilities, and long-term care environments. The recurring and predominantly single-use nature of these products creates sustained replacement demand and supports continuous institutional procurement.
The expansion of healthcare infrastructure and institutional care networks is further supporting market growth. Increasing hospital capacity, ambulatory surgical activity, ageing populations, and greater utilization of post-acute and home healthcare services are strengthening demand for surgical products, wound-management disposables, underpads, adult incontinence products, and related medical supplies. Asia Pacific is particularly benefiting from expanding healthcare access and hospital infrastructure, while established markets such as the U.S. continue to generate recurring demand through large elderly populations and extensive post-acute care networks.
Product innovation and regulatory developments are also reshaping competitive dynamics. Manufacturers are increasingly developing advanced absorbent materials, smart wound dressings, antimicrobial and X-ray detectable materials, sustainable fibers, and reduced-plastic solutions. At the same time, regulations such as the U.S. FDA's Quality Management System Regulation, effective from February 2, 2026, are increasing requirements related to quality management, supplier controls, risk management, documentation, and inspection readiness for applicable medical-device manufacturers. Growing environmental concerns surrounding single-use medical waste and relatively high raw-material and manufacturing costs, however, remain important challenges for market participants.